Transforming ultrasound from imaging to cure.
Salt Lake City, UT
Joined November 2023
- Tweets9
- Following68
- Followers11
- Likes1
Microvascular Therapeutics retweeted
Happy #NewMemberMonday!
💼 @Calibre1Search places top talent into iconic corporate giants and VC-backed companies
🏙️ @Fremont_CA delivers public service and safety for everyone who lives and works in Fremont
💡 @nanobbl pioneers ultrasound contrast agents and theranostics
ALT Please join us in welcoming our new members to the Biocom California community: Acelot Aveera Medical Calibre One City of Fremont Makani Science Microvascular Therapeutics
Microvascular Therapeutics retweeted
Congratulations to Microvascular Therapeutic of Tucson, AZ, one of the 14 winners of the 2025 @Pepperdine @GraziadioSchool Most Fundable Companies Competition in Malibu, CA. Microvascular Therapeutics develops patented ultrasound microbubble and nanobubble platforms, targeting multi-billion-dollar cardiovascular, oncology, and neurology markets by transforming ultrasound from diagnostic imaging to cure. mvtpharma.com/ @nanobbl @TucsonStar @tucson_az @TucsonSmallBiz @azbiz
We received positive results from our phase II study of our drug candidate, CardiSon, a microbubble contrast agent for echocardiography. mvtpharma.com/post/positive-…
Evan Unger, CEO and Founder of MVT, was honored to present MVT at the Biotech Showcase last week, thanks to NIH Seed. We are grateful to the
@nihseed for their ongoing support of MVT's technology and growth.
We are thrilled to have completed enrollment for our Phase II clinical study for our new contrast agent MVT-100 shorturl.at/7hm4g
Dr. Evan Unger, CEO and Founder of Microvascular Therapeutics (MVT), has been awarded the 2024 Harry Fischer Award by Contrast Media Research (CMR) in recognition of his exceptional contributions to the field of contrast media research. shorturl.at/af5kU
